Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor

A method of inducing BEF-1 transcription factor comprising administering to a human in need thereof an effective amount of a compound having the formula wherein R and R are independently hydrogen, -CH3, or wherein Ar is optionally substituted phenyl; R is selected from the group consisting of pyrrol...

Full description

Saved in:
Bibliographic Details
Main Authors BERG, DAVID THOMPSON, CALNEK, DAVID SCOTT, GRINNELL, BRIAN WILLIAM
Format Patent
LanguageGerman
Published 06.02.2003
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method of inducing BEF-1 transcription factor comprising administering to a human in need thereof an effective amount of a compound having the formula wherein R and R are independently hydrogen, -CH3, or wherein Ar is optionally substituted phenyl; R is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Bibliography:Application Number: DE19966022472T